CSR push: NSE to invest Rs 380-cr for cancer facility at Tata Memorial Centre; India’s largest BMT centre to set up
India’s largest equity bourse, NSE, will invest Rs 380 crore to build a new 11-storey multi-speciality cancer treatment block and India’s largest bone marrow transplant centre at TMH-run ACTREC in Navi Mumbai. Expected by July 2027, this CSR-funded facility aims to handle 1.3 lakh outpatient visits annually and over 600 BMTs, significantly addressing critical healthcare gaps for cancer patients.🕒 1 min read
India’s largest equity bourse, NSE, will invest Rs 380 crore to build a new 11-storey multi-speciality cancer treatment block and India’s largest bone marrow transplant centre at TMH-run ACTREC in Navi Mumbai. Expected by July 2027, this CSR-funded facility aims to handle 1.3 lakh outpatient visits annually and over 600 BMTs, significantly addressing critical healthcare gaps for cancer patients.
Continue Reading
-
Bangladesh Rushes For ‘Secret’ US Trade Deal After India’s Tariff Gains
- Q1 earnings, trade talks to guide markets: Analysts
- Hardik fitness update: All-rounder set to play domestic cricket for Baroda; comeback date revealed
- Boom or skewed spike? India’s exports to China jump 90% – but why there is little reason to cheer
-
‘Never celebrate a loss’: Gambhir reveals India’s mindset ahead of 2026 T20 World Cup
- Pongal Explained: How A Word Came To Define Both A Festival And A Feast
-
Gambhir and Gill: Accidental partnership one push away from ‘significant’ scoreline
- At 0.5%, core sector grows at slowest pace in 7 months
- Sebi sets Rs 20,000 crore threshold for ‘significant indices’; Sensex, Nifty among benchmarks covered
- Boost for IAF! HAL looks to secure billion-dollar GE engine deal for LCA Tejas Mk1A; India-US defence ties in focus
